RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Ben Tre Pharmaceutical JSC Stock

Ben Tre Pharmaceutical JSC Equity 2024

Ben Tre Pharmaceutical JSC Equity

239.92 B VND

Ticker

DBT.VN

ISIN

VN000000DBT6

In 2024, Ben Tre Pharmaceutical JSC's equity was 239.92 B VND, a 10.28% increase from the 217.55 B VND equity in the previous year.

Ben Tre Pharmaceutical JSC Aktienanalyse

What does Ben Tre Pharmaceutical JSC do?

Ben Tre Pharmaceutical JSC ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Ben Tre Pharmaceutical JSC's Equity

Ben Tre Pharmaceutical JSC's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Ben Tre Pharmaceutical JSC's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Ben Tre Pharmaceutical JSC's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Ben Tre Pharmaceutical JSC's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Ben Tre Pharmaceutical JSC’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Ben Tre Pharmaceutical JSC stock

What is the equity of Ben Tre Pharmaceutical JSC this year?

Ben Tre Pharmaceutical JSC has equity of 239.92 B VND this year.

What was the equity of Ben Tre Pharmaceutical JSC compared to the previous year?

The equity of Ben Tre Pharmaceutical JSC has increased/decreased by 10.28% increased compared to the previous year.

What impact does a high equity have on investors of Ben Tre Pharmaceutical JSC?

A high equity is advantageous for investors of Ben Tre Pharmaceutical JSC as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Ben Tre Pharmaceutical JSC?

A low equity can be a risk for investors of Ben Tre Pharmaceutical JSC, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Ben Tre Pharmaceutical JSC affect the company?

An increase in equity of Ben Tre Pharmaceutical JSC can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Ben Tre Pharmaceutical JSC affect the company?

A reduction in equity of Ben Tre Pharmaceutical JSC can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Ben Tre Pharmaceutical JSC?

Some factors that can affect the equity of Ben Tre Pharmaceutical JSC include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Ben Tre Pharmaceutical JSC so important for investors?

The equity of Ben Tre Pharmaceutical JSC is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Ben Tre Pharmaceutical JSC take to change the equity?

To change equity, Ben Tre Pharmaceutical JSC can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Ben Tre Pharmaceutical JSC pay?

Over the past 12 months, Ben Tre Pharmaceutical JSC paid a dividend of 636.36 VND . This corresponds to a dividend yield of about 5.22 %. For the coming 12 months, Ben Tre Pharmaceutical JSC is expected to pay a dividend of 0 VND.

What is the dividend yield of Ben Tre Pharmaceutical JSC?

The current dividend yield of Ben Tre Pharmaceutical JSC is 5.22 %.

When does Ben Tre Pharmaceutical JSC pay dividends?

Ben Tre Pharmaceutical JSC pays a quarterly dividend. This is distributed in the months of May, December, November, March.

How secure is the dividend of Ben Tre Pharmaceutical JSC?

Ben Tre Pharmaceutical JSC paid dividends every year for the past 0 years.

What is the dividend of Ben Tre Pharmaceutical JSC?

For the upcoming 12 months, dividends amounting to 0 VND are expected. This corresponds to a dividend yield of 0 %.

In which sector is Ben Tre Pharmaceutical JSC located?

Ben Tre Pharmaceutical JSC is assigned to the 'Health' sector.

Wann musste ich die Aktien von Ben Tre Pharmaceutical JSC kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Ben Tre Pharmaceutical JSC from 3/15/2021 amounting to 700 VND, you needed to have the stock in your portfolio before the ex-date on 2/19/2021.

When did Ben Tre Pharmaceutical JSC pay the last dividend?

The last dividend was paid out on 3/15/2021.

What was the dividend of Ben Tre Pharmaceutical JSC in the year 2023?

In the year 2023, Ben Tre Pharmaceutical JSC distributed 636.364 VND as dividends.

In which currency does Ben Tre Pharmaceutical JSC pay out the dividend?

The dividends of Ben Tre Pharmaceutical JSC are distributed in VND.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Ben Tre Pharmaceutical JSC

Our stock analysis for Ben Tre Pharmaceutical JSC Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Ben Tre Pharmaceutical JSC Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.